The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Viral Vector Manufacturing Market Increase Between 2026 And 2030?
The viral vector manufacturing market has seen rapid expansion in recent years. It is anticipated to increase from $8.26 billion in 2025 to $9.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.9%. The historical growth of this market can be attributed to challenges such as limited manufacturing capacity, high production costs, reliance on traditional gene delivery methods, existing regulatory barriers, and fragmented supply chains.
The viral vector manufacturing market is projected to experience rapid expansion over the coming years, reaching $21.31 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 21.1%. This anticipated growth during the forecast period is fueled by factors such as the increasing need for gene and cell therapies, progress in viral vector technology, greater investments in research and development, the expansion of contract manufacturing organizations, and the growing uptake of personalized medicine. Key trends anticipated for this period encompass breakthroughs in gene therapy, improvements in viral vector safety, the development of scalable manufacturing methods, strengthened regulatory adherence, and sophisticated upstream and downstream processing techniques.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12398&type=smp
Which Growth Drivers Are Expected To Support The Viral Vector Manufacturing Market Forward?
The rising occurrence of cancer and infectious diseases is anticipated to boost the expansion of the viral vector manufacturing market in the future. An infectious disease is defined as an ailment caused by a virus or its harmful secretions, transmitted to a vulnerable host through interaction with an infected individual, animal, or object. Cancer encompasses numerous conditions that can originate in any bodily organ or tissue when abnormal cells proliferate uncontrollably, breaching their normal limits to invade adjacent organs and metastasize to others. Viral vectors are utilized to produce tumor antigens, which are proteins found on tumor cells, thereby stimulating the body’s immune system to fight cancer. Moreover, viral vectors have demonstrated utility as vaccines against diverse infectious illnesses in both pre-clinical and clinical studies. For instance, data from July 2024, provided by the Australian Institute of Health and Welfare, a government agency based in Australia, showed that in Australia, cancer diagnoses rose from 160,570 in 2022 to 164,694 in 2023, indicating a significant annual increase. This trajectory underscores the increasing incidence of cancer nationwide. Furthermore, an August 2024 report from the UK Health Security Agency, a UK-based executive agency, revealed that in England, the UK Health Security Agency (UKHSA) documented 368 measles cases in 2023, which represents an almost sevenfold increase from the 53 cases recorded in 2022, with the West Midlands and London together comprising 44% and 33% of these cases, respectively. Consequently, the rising prevalence of both cancer and infectious diseases is a key factor propelling the expansion of the viral vector manufacturing market.
What Segment Types Are Included In The Viral Vector Manufacturing Market Analysis?
The viral vector manufacturing market covered in this report is segmented –
1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types
2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research
5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Other End Users
Subsegments:
1) By Adenoviral Vectors: Serotype 5, Serotype 2, Serotype 26
2) By Adeno-Associated Viral Vectors: AAV2, AAV5, AAV8, AAV9, Others
3) By Lentiviral Vectors: HIV-1-Based Lentiviral Vectors, SIV-Based Lentiviral Vectors, Others
4) By Retroviral Vectors: Moloney Murine Leukemia Virus (MoMLV), Gammaretroviral Vectors, Others
5) By Other Types: Sendai Viral Vectors, Vesicular Stomatitis Virus (VSV)-Based Vectors, Measles Virus Vectors, Others
Which Trends Are Affecting The Viral Vector Manufacturing Market Framework?
Leading companies within the viral vector manufacturing market are concentrating on creating advanced products, including viral vector platforms specifically designed for viral vector production and manufacturing. These platforms are comprehensive systems engineered to efficiently produce and process viral vectors for applications such as gene therapy and vaccine development. For instance, in May 2023, AGC Biologics, a US-based global biopharmaceutical contract development and manufacturing organization (CDMO), launched its BravoAAV and ProntoLVV platforms, which are designed to offer flexible and accelerated vector development and manufacturing for cell and gene therapy programs. Such platforms enable GMP product delivery within nine months, bolstered by a global regulatory and supply network and in-house plasmid DNA services. Featuring custom processes, templated material approaches, and prequalified analytical methods, these platforms are substantial contributors to the viral vector manufacturing market’s projected growth, reaching $5.5 billion by 2035, as they fulfill the increasing demand for efficient development and delivery of life-changing gene therapies and vaccines.
Which Organizations Are Involved In The Viral Vector Manufacturing Market?
Major companies operating in the viral vector manufacturing market are Sanofi S.A., Merck Group, FUJIFILM Holdings Corporation, Lonza Group, Catalent Inc., AGC Biologics, Ultragenyx Pharmaceutical Inc., Novasep Holding SAS, Aldevron LLC, Oxford Biomedica plc, LakePharma Inc., Voyager Therapeutics Inc., Mustang Bio Inc., Regenxbio Inc., VGXI Inc., BioNTech IMFS GmbH, FinVector Oy, Vigene Biosciences Inc., Univercells Technologies, Sirion-Biotech GmbH, Cevec Pharmaceuticals GmbH, Batavia Biosciences BV
Access The Complete Viral Vector Manufacturing Market Report:
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report
Which Region Contributes The Most To The Viral Vector Manufacturing Market?
North America was the largest region in the viral vector manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Viral Vector Manufacturing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12398&type=smp
Browse Through More Reports Similar to the Global Viral Vector Manufacturing Market 2026, By The Business Research Company
Viral Vector Manufacturing Market Report 2026
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report
Viral And Non Viral Vector Manufacturing Market Report 2026
Oral Expectorant Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model